Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Population of Adult Obese Patients
Key claim: An observational study protocol investigates the prevalence, clinical risk factors, and specific plasma and urinary biomarkers of sarcopenic obesity in adults aged 18 to 70.
Abstract
This project aims first to determine the prevalence of sarcopenia in a population of obese people of extended age group (18-70 years). In a second step, the factors determining and / or predisposing to sarcopenic obesity will be identified as well as plasmatic and urinary biomarkers specific to this phenotype.
Why this matters
An observational study protocol investigates the prevalence, clinical risk factors, and specific plasma and urinary biomarkers of sarcopenic obesity in adults aged 18 to 70.